This is a routine annual meeting with no surprises. Investors should vote on the board nominees and compensation package, but no immediate trading action is required.
MNKD drugs
MNKD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 8 $2.61entry
- T+1 · 7mo ago −1.92%α −2.49% · $2.56
- T+5 · 7mo ago +6.13%α +2.61% · $2.77
- T+20 · 7mo ago +9.58%α +1.03% · $2.86
- T+60 · 4mo ago +73.18%α +62.72% · $4.52
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
MannKind Corp (MNKD) is holding its 2024 Annual Meeting, where shareholders will vote on the re-election of nine board nominees, approval of executive compensation, and ratification of Deloitte & Touche LLP as auditors. The filing is a standard annual proxy statement with no material changes or activist involvement.
Key Financial Metrics
Key Facts
- Annual shareholder meeting scheduled for May 15, 2024
- Nine board nominees up for re-election
- Vote on advisory approval of executive compensation
- Vote to ratify Deloitte & Touche LLP as auditors
- No activist involvement or special proposals
Financial Impact
No immediate financial impact
Risk Factors
- Low shareholder engagement on executive compensation vote
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-145620 |
| Document: 0001193125-26-145620-index-headers.html | 0001193125-26-145620 |
| Document: 0001193125-26-145620-index.html | 0001193125-26-145620 |
| Document: 0001193125-26-145620.txt | 0001193125-26-145620 |
Track record
17 reports on MNKD
7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +20.00% at T+60 after the May 27, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $4.23 Now $3.96 −6.38% settles Dec 9
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Bearish 5/10 Entry $3.90 Now $3.96 −1.54% settles Dec 7
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $3.73 Now $3.96 +6.17% settles Dec 2
- Jul 29, 202615w ago Press Release Bullish 6/10 Entry $3.85 to $4.09 Now $3.96 +2.86% ▲ +6.23% +1.21% vs SPY
- Jul 24, 202616w ago 8-K Mixed 6/10 Entry $3.95 to $4.07 Now $3.96 +0.25% ▲ +3.04% −0.26% vs SPY
- Jul 17, 202617w ago Insider Cluster Neutral 3/10 Entry $3.98 to $3.90 Now $3.96 −0.50% ▼ −2.01% −6.13% vs SPY
- Jun 3, 202623w ago Press Release Neutral 5/10 Entry $3.36 to $4.52 Now $3.96 +17.86% ▲ +34.52% +35.52% vs SPY
- Jun 2, 202623w ago 8-K Bullish 7/10 Entry $3.43 to $4.05 Now $3.96 +15.45% ▲ +18.08% +19.64% vs SPY
- May 29, 202624w ago Press Release Bullish 8/10 Entry $3.77 to $4.24 Now $3.96 +5.04% ▲ +12.47% +14.26% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers